Skip to main content
Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
13.26
+1.70 (14.71%)
At close: Aug 13, 2025, 4:00 PM
13.25
-0.01 (-0.08%)
After-hours: Aug 13, 2025, 6:59 PM EDT

Ginkgo Bioworks Holdings Revenue by Segment
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
Cell Engineering
184.31M 173.97M 166.16M 128.25M 137.32M 143.53M 169.81M 157.32M
Cell Engineering Growth
34.22% 21.21% -2.15% -18.48% -12.13% -0.09% 36.32% 16.86%
Biosecurity Services
53.10M 53.07M 51.79M 49.59M 54.09M 78.98M 103.79M 128.56M
Biosecurity Services Growth
-1.82% -32.80% -50.10% -61.42% -73.03% -73.55% -72.09% -65.27%
Biosecurity Products
- - - - - - 41.38M 40.08M 33.17M 35.46M 31.44M 34.74M 31.21M 23.04M
Biosecurity Products Growth
- - - - - - 31.61% 15.34% 6.29% 53.88% - - - -

Total Active Customers
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
Active Customers
330.00 325.00 320.00 301.00 279.00 253.00 220.00 193.00
Active Customers Growth
18.28% 28.46% 45.45% 55.96% 69.09% 79.43% 76.00% 73.87%

Total Active Programs
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
Active Programs
602.00 619.00 612.00 545.00 492.00 449.00 414.00 383.00
Active Programs Growth
22.36% 37.86% 47.83% 42.30% 40.17% 41.19% 46.81% 52.59%

Operating Income by Segment
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
Biosecurity
-24.59M -30.62M -32.55M -27.53M -24.12M -3.19M 9.03M 9.86M
Cell Engineering
-178.98M -239.65M -312.58M -395.46M -391.36M -425.23M -424.51M -408.47M
Biosecurity Growth
- - - - - - -91.63% -91.43%

Operating Expense Breakdown
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
Research & Development
358.53M 424.06M 464.72M 544.38M 554.44M 580.62M 644.74M 747.66M
Research & Development Growth
-35.34% -26.96% -27.92% -27.19% -37.94% -44.93% -65.30% -54.73%
General & Administrative
224.92M 246.16M 278.09M 307.82M 343.88M 385.03M 417.22M 770.38M
General & Administrative Growth
-34.59% -36.07% -33.35% -60.04% -68.92% -73.07% -80.04% -54.25%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.